Ken Myszkowski
Equibles does not estimate personal net worth.
About Ken Myszkowski
Earlier roles on record: CFO at Arrowhead Pharmaceuticals, Inc. (ARWR) until May 13, 2025. Arrowhead Pharmaceuticals, Inc. reported in an 8-K filed April 15, 2025 that Ken Myszkowski retired as Chief Financial Officer, effective May 13, 2025. Ken Myszkowski has spoken on 19 earnings calls across 1 company, most recently for Arrowhead Pharmaceuticals, Inc. on February 10, 2025. The companies whose calls Ken Myszkowski spoke on are classified in the Healthcare sector.
“On, April 9, 2025 Ken Myszkowski notified Arrowhead Pharmaceuticals, Inc. (the "Company") of his decision to retire as Chief Financial Officer of the Company, effective as of May 13, 2025 (the "Effective Date").”
Ken Myszkowski on recent calls
“As we reported today, our net loss for the quarter ended December 31, 2024, was $173.1 million or $1.39 per share based on 124.8 million fully diluted weighted average shares outstanding.”
“As we reported today, our net loss for fiscal 2024 was $599.5 million or $5 per share based on $119.8 million fully diluted weighted average shares outstanding.”
“As we reported today, our net loss for the quarter ended June 30, 2024, was $170.8 million or $1.38 per share based on $124.2 million fully diluted weighted average shares outstanding.”
“As we reported today, our net loss for the quarter ended March 31, 2024, was $125.3 million or $1.02 per share based on 123.3 million fully diluted weighted average shares outstanding.”
“As we reported today, our net loss for the quarter ended December 31, 2023, was $132.9 million or $1.24 per share, based on $107.4 million fully diluted weighted average shares outstanding.”
Affiliation history
-
Start not stated–2025-05-13